The burden of multidrug resistance in Gram-negative bacilli (GNB) now represents a daily
issue for the management of antimicrobial therapy in intensive care unit (ICU) patients. In …

In the last 10 years, extended-spectrum β-lactamase-producing enterobacteria (ESBL-E)
have become one of the main challenges for antibiotic treatment of enterobacterial …

Healthcare‐associated infections due to multidrug‐resistant Gram‐negative bacteria (MDR‐
GNB) are a leading cause of morbidity and mortality worldwide. These evidence‐based …

Background Patients with blood disorders colonized with antibiotic-resistant bacteria (ARB)
are prone to systemic infections that are difficult to treat. Reintroduction of commensal …

Background Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as important
health care-associated pathogens. Colonization precedes infection but the risk of …

Scope The aim of these guidelines is to provide recommendations for decolonizing
regimens targeting multidrug-resistant Gram-negative bacteria (MDR-GNB) carriers in all …

Introduction: Management of antimicrobial resistance in multi-drug-resistant-Klebsiella
pneumoniae (MDR-KP) is a major challenge for clinicians. The optimal treatment option for …

Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense
against multidrug‐resistant Gram‐negative organisms. Over the last decade, carbapenem …

The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …

Background Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-
KP) has become one of the most important contemporary pathogens, especially in endemic …